CancerNetwork® at The 2024 Kidney Cancer Research Summit (KCRS)
 |
| Updates at KCRS 2024 Nivolumab Combo May Show Long-Term Benefits in Advanced RCC Data from CheckMate 214 show a steady improvement in overall survival with nivolumab/ipilimumab in patients with favorable-risk disease. Read More |
| Liquid Biopsy May Help Detect Sarcomatoid Features in Renal Cell Carcinoma An epigenomic profiling approach may help pick up the entire tumor burden, thereby assisting with detecting sarcomatoid features in those with RCC. Read More |